Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies To Support Stem Cell / Laser Regenerative Therapy For COPD

Links shared publicly online about this topic.

  • 1,406
    total visits

Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies To Support Stem Cell / Laser Regenerative Therapy For COPD

medicalnewstoday.com —

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) announced that its majority owned subsidiary, Entest BioMedical Inc. (OTCBB: ENTB) has initiated studies to support the Company's stem cell / laser

View full resource at medicalnewstoday.com

Tags: COPD, Stem Cell

  • Share

Most Recently Shared on February 4, 2010 at 2:13 pm By:

mnt_stemcell MNT Stem Cell News

Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies To Support Stem Cell / Las... http://mnt.to/3xbq

2 years ago...

Reply

Retweet

Favorite

Advertisement